Rose Higgins, chief executive officer at HealthMyne, sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.
All content for RefleXion Podcast is the property of RefleXion and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rose Higgins, chief executive officer at HealthMyne, sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.
Dr. Sean Shirvani, SVP of Clinical and Medical Affairs for Reflexion, shares his thinking about the word no one wants to hear: Metastasized. Worldwide, metastatic disease is responsible for 9 of 10 cancer deaths. This is grim on a global scale. But there is hope. Every year brings new treatment discoveries, and the momentum is building. In this series, Dr. Shirvani and his guests explore The Future of Cancer.Speakers:Sean Shirvani, M.D. - Chief Medical Officer, RefleXionFor more information, ...
RefleXion Podcast
Rose Higgins, chief executive officer at HealthMyne, sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.
